Literature DB >> 9665278

Giant granules of neutrophils in Chediak-Higashi syndrome are derived from azurophil granules but not from specific and gelatinase granules.

L Kjeldsen1, J Calafat, N Borregaard.   

Abstract

The abnormal giant granules of Chediak-Higashi syndrome (CHS) neutrophils in humans are thought to be derived from both azurophil and specific granules, whereas the presence of gelatinase granules and their contribution to giant granule formation has not been investigated previously. We have examined the ultrastructure and mobilization of neutrophil granules from a patient with CHS by immunogold electron microscopy and exocytosis experiments of isolated leukocytes. The giant granules contained the azurophil granule components myeloperoxidase and CD63. We found no evidence of involvement of specific or gelatinase granules in the formation of giant granules because lactoferrin and gelatinase were contained in normal-appearing peroxidase-negative granules. On stimulation of leukocytes with N-formyl-methionyl-leucyl-phenylalanine and the calcium ionophore, ionomycin, there was a diminished exocytosis of myeloperoxidase in CHS compared with a healthy control, indicating a lack of mobilization of the giant granules. On the other hand, there was a normal or augmented release of lactoferrin and gelatinase in CHS neutrophils, with gelatinase granules being the most easily mobilized, as known from normal neutrophils. In conclusion, giant granules from CHS neutrophils originate from azurophil granules but not from the specific and gelatinase granules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665278     DOI: 10.1002/jlb.64.1.72

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

Review 1.  Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics.

Authors:  Marjan Huizing; Amanda Helip-Wooley; Wendy Westbroek; Meral Gunay-Aygun; William A Gahl
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

2.  Chediak-Higashi syndrome: a review of the past, present, and future.

Authors:  Prashant Sharma; Elena-Raluca Nicoli; Jenny Serra-Vinardell; Marie Morimoto; Camilo Toro; May Christine V Malicdan; Wendy J Introne
Journal:  Drug Discov Today Dis Models       Date:  2019-12-09

3.  Chediak-higashi syndrome presented as accelerated phase: case report and review of the literature.

Authors:  Amina Bouatay; Sondes Hizem; Amel Tej; Wided Moatamri; Lamia Boughamoura; Mondher Kortas
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-31       Impact factor: 0.900

4.  Effects of recombinant granulocyte-colony stimulating factor administration during Mycobacterium avium infection in mice.

Authors:  A S Gonçalves; R Appelberg
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

5.  Neutrophil-derived cathelicidin protects from neointimal hyperplasia.

Authors:  Oliver Soehnlein; Sarawuth Wantha; Sakine Simsekyilmaz; Yvonne Döring; Remco T A Megens; Sebastian F Mause; Maik Drechsler; Ralf Smeets; Stefan Weinandy; Fabian Schreiber; Thomas Gries; Stefan Jockenhoevel; Martin Möller; Santosh Vijayan; Marc A M J van Zandvoort; Birgitta Agerberth; Christine T Pham; Richard L Gallo; Tilman M Hackeng; Elisa A Liehn; Alma Zernecke; Doris Klee; Christian Weber
Journal:  Sci Transl Med       Date:  2011-10-05       Impact factor: 17.956

6.  Understanding neutropenia secondary to intrinsic or iatrogenic immune dysregulation.

Authors:  Kelly Walkovich; James A Connelly
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 7.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

8.  Human neutrophils secrete bioactive paucimannosidic proteins from azurophilic granules into pathogen-infected sputum.

Authors:  Morten Thaysen-Andersen; Vignesh Venkatakrishnan; Ian Loke; Christine Laurini; Simone Diestel; Benjamin L Parker; Nicolle H Packer
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

9.  Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A.

Authors:  Yair Anikster; Marjan Huizing; Paul D Anderson; Diana L Fitzpatrick; Aharon Klar; Eva Gross-Kieselstein; Yackov Berkun; Gila Shazberg; William A Gahl; Haggit Hurvitz
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

Review 10.  Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism.

Authors:  Laura Dotta; Silvia Parolini; Alberto Prandini; Giovanna Tabellini; Maddalena Antolini; Stephen F Kingsmore; Raffaele Badolato
Journal:  Orphanet J Rare Dis       Date:  2013-10-17       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.